Literature DB >> 9448966

Morbidity from abdominal radiotherapy in the First United Kingdom Children's Cancer Study Group Wilms' Tumour Study. United Kingdom Children's Cancer Study Group.

R E Taylor1.   

Abstract

Between 1980 and 1986, 384 children were entered into the UKCCSG First Wilms' Tumour Study (UKW1). For 171 patients receiving abdominal radiotherapy (RT) the early and late toxicity has been analysed. Major early toxicity was significantly more likely with whole abdominal (48%) compared with flank (21%) RT (P = 0.007). An increased risk of major early toxicity, which did not reach statistical significance, was seen with right (20.5%) compared with left (7%) flank RT (P = 0.063) and in those treated with a RT dose of > 20 Gy compared with a dose of < or = 20 Gy (P = 0.103). There were 138 evaluable survivors, with a median follow-up of 127 months. Of these, 33 (23.9%) were reported to have late effects, including 27 musculoskeletal (19.6%), four gastrointestinal (2.9%), and three (of 68 girls) ovarian failure (4.4%). There was no apparent effect of age at diagnosis, RT dose or field size on the risk of developing late effects. The continued surveillance of the long term survivors of Wilms' tumour for the late effects of treatment will be important.

Entities:  

Mesh:

Year:  1997        PMID: 9448966     DOI: 10.1016/s0936-6555(97)80131-8

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  10 in total

1.  Outcomes of children with favorable histology wilms tumor and peritoneal implants treated in National Wilms Tumor Studies-4 and -5.

Authors:  John A Kalapurakal; Daniel M Green; Gerald Haase; James R Anderson; Jeffrey S Dome; Paul E Grundy
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-06-01       Impact factor: 7.038

Review 2.  A systematic review of selected musculoskeletal late effects in survivors of childhood cancer.

Authors:  Prasad L Gawade; Melissa M Hudson; Sue C Kaste; Joseph P Neglia; Karen Wasilewski-Masker; Louis S Constine; Leslie L Robison; Kirsten K Ness
Journal:  Curr Pediatr Rev       Date:  2014

3.  Hepatic late adverse effects after antineoplastic treatment for childhood cancer.

Authors:  Renée L Mulder; Dorine Bresters; Malon Van den Hof; Bart Gp Koot; Sharon M Castellino; Yoon Kong K Loke; Piet N Post; Aleida Postma; László P Szőnyi; Gill A Levitt; Edit Bardi; Roderick Skinner; Elvira C van Dalen
Journal:  Cochrane Database Syst Rev       Date:  2019-04-15

Review 4.  Wilms tumour: prognostic factors, staging, therapy and late effects.

Authors:  Sue C Kaste; Jeffrey S Dome; Paul S Babyn; Norbert M Graf; Paul Grundy; Jan Godzinski; Gill A Levitt; Helen Jenkinson
Journal:  Pediatr Radiol       Date:  2007-11-17

Review 5.  Wilms tumour: diagnosis and treatment.

Authors:  M J Coppes; J E Wolff; M L Ritchey
Journal:  Paediatr Drugs       Date:  1999 Oct-Dec       Impact factor: 3.930

6.  Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer.

Authors:  Esmee Cm Kooijmans; Arend Bökenkamp; Nic S Tjahjadi; Jesse M Tettero; Eline van Dulmen-den Broeder; Helena Jh van der Pal; Margreet A Veening
Journal:  Cochrane Database Syst Rev       Date:  2019-03-11

7.  Impairments that influence physical function among survivors of childhood cancer.

Authors:  Carmen L Wilson; Prasad L Gawade; Kirsten K Ness
Journal:  Children (Basel)       Date:  2015

8.  The Dutch LATER physical outcomes set for self-reported data in survivors of childhood cancer.

Authors:  Nina Streefkerk; Wim J E Tissing; Margriet van der Heiden-van der Loo; Elizabeth A M Lieke Feijen; Eline van Dulmen-den Broeder; Jacqueline J Loonen; Helena J H van der Pal; Cécile M Ronckers; Hanneke M van Santen; Marleen H van den Berg; Renée L Mulder; Joke C Korevaar; Leontine C M Kremer
Journal:  J Cancer Surviv       Date:  2020-05-03       Impact factor: 4.442

9.  Validation of questionnaire-reported chest wall abnormalities with a telephone interview in Swiss childhood cancer survivors.

Authors:  Rahel Kasteler; Christa Lichtensteiger; Christina Schindera; Marc Ansari; Claudia E Kuehni
Journal:  BMC Cancer       Date:  2021-07-08       Impact factor: 4.430

Review 10.  The clinical case for proton beam therapy.

Authors:  Robert L Foote; Scott L Stafford; Ivy A Petersen; Jose S Pulido; Michelle J Clarke; Steven E Schild; Yolanda I Garces; Kenneth R Olivier; Robert C Miller; Michael G Haddock; Elizabeth Yan; Nadia N Laack; Carola A S Arndt; Steven J Buskirk; Vickie L Miller; Christopher R Brent; Jon J Kruse; Gary A Ezzell; Michael G Herman; Leonard L Gunderson; Charles Erlichman; Robert B Diasio
Journal:  Radiat Oncol       Date:  2012-10-22       Impact factor: 3.481

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.